Harvard Bioscience Inc HBIO

$7.48 -0.93% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q FORM 10-Q 2026-08-11 View →
8-K FORM 8-K 2026-08-11 View →
8-K FORM 8-K 2026-08-11 View →
4 Insider transaction 2026-06-12 View →
4 Insider transaction 2026-06-11 View →
4 Insider transaction 2026-06-11 View →
4 Insider transaction 2026-06-11 View →
4 Insider transaction 2026-06-11 View →
8-K FORM 8-K 2026-06-02 View →
10-Q FORM 10-Q 2026-05-12 View →
8-K FORM 8-K 2026-05-12 View →
8-K FORM 8-K 2026-05-12 View →
DEF 14A FORM DEF 14A 2026-04-21 View →
4 Insider transaction 2026-04-01 View →
4 Insider transaction 2026-04-01 View →
4 Insider transaction 2026-03-23 View →
4 Insider transaction 2026-03-18 View →
4 Insider transaction 2026-03-18 View →
4 Insider transaction 2026-03-17 View →
8-K FORM 8-K 2026-03-17 View →
10-K FORM 10-K 2026-03-13 View →
8-K FORM 8-K 2026-03-12 View →
8-K FORM 8-K 2026-03-10 View →
8-K FORM 8-K 2026-03-06 View →
8-K FORM 8-K 2026-02-10 View →
DEF 14A DEF 14A 2026-01-30 View →
S-3 FORM S-3 2026-01-30 View →
8-K FORM 8-K 2026-01-29 View →
8-K FORM 8-K 2026-01-20 View →
8-K FORM 8-K 2026-01-12 View →
4 Insider transaction 2025-12-30 View →
8-K FORM 8-K 2025-12-17 View →
8-K FORM 8-K 2025-12-05 View →
10-Q FORM 10-Q 2025-11-06 View →
8-K FORM 8-K 2025-11-06 View →
4 Insider transaction 2025-10-07 View →
8-K FORM 8-K 2025-10-03 View →
8-K FORM 8-K 2025-09-09 View →
4 OWNERSHIP DOCUMENT 2025-08-19 View →
8-K FORM 8-K 2025-08-13 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$7.48
Market Cap
$34.05 million
52-Week Range
$3.75 – $9.40
Average Volume
18K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.